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Abstract  
Objective: To examine the risk of past and current experiences of intimate partner violence 
(IPV) in women with severe mental illness in pregnancy. 
Methods: We examined past and current experiences of intimate partner violence in women 
with Severe Mental Illness (SMI) in pregnancy. The data of 304 women with SMI, including 
Schizophrenia and psychotic disorders and Bipolar Disorder meeting ICD-10-AM criteria 
was extracted from hospital records at King Edward Memorial Hospital, Western Australia. 
Comparisons with our study data and Australian population data reported by the Australian 
Bureau of Statistics, which includes data on pregnant women in Western Australia. 
Additional measures included reported demographics, substance use and pregnancy variables. 
Results: 48% of pregnant women with SMI had experienced IPV and were 3 times the risk 
when compared to the general pregnant population in Australia. There was no difference in 
rates of IPV in those women with psychotic disorders when compared to bipolar disorder. 
Furthermore, the rates of smoking and illicit substance use were significantly higher in 
pregnant women with SMI who experienced IPV compared to those who have not 
experienced IPV 
Conclusions These findings suggest women with SMI in pregnancy are at significantly 
higher risk of having experienced or experiencing IPV. In addition, IPV in pregnant women 
with SMI may increase the risk of smoking and illicit substance use. Together this suggests 
that maternity and mental health services should ensure there are both screening and support 
pathways that are developed and evaluated specifically for pregnant women with SMI. 
Keywords: Severe Mental Illness, Domestic Violence, Pregnancy, Schizophrenia, Bipolar 
Disorder 
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Introduction 
Intimate Partner Violence (IPV) is a major public health and societal concern and research 
suggests that women are at an increased risk of IPV during pregnancy (Johnson et al., 2003; 
Burch and Gallup, 2004). The World Health Organisation defines intimate partner violence as 
“behaviour that causes physical, sexual or psychological harm including acts of physical 
aggression, sexual coercion, psychological abuse and controlling behaviour by an existing or 
previous intimate partner” (Garcia-Moreno et al., 2006).  According to the Australian Bureau 
of Statistics Personal Safety Survey (2016), “women were nearly three times more likely to 
have experienced partner violence than men with approximately one in six women (17% or 
1.6million) and one in sixteen men (6.1% or 547,600) having experienced partner violence 
since the age of 15”  (Cox, 2015; ABO, 2013). The 2012 ABS’ Personal Safety Survey (2013) 
in Australia has identified violence against women as a serious public health problem. The 
survey demonstrated 36% of women over the age of 18 have experienced physical and/or sexual 
violence by a known perpetrator since the age of 15; of those, 22% have experienced physical 
violence during pregnancy by a current partner and 25% by a partner from a previous 
relationship (Statistics, 2013). Furthermore, of those who experienced violence during 
pregnancy by a previous partner, 25% reported that violence first occurred during the 
pregnancy.  
A project conducted in Australia between 2009 and 2015 identified the financial impact of 
intimate partner violence and concluded that the total cost of IPV to the community was 
$51,879,096 (2009-2015) (Department of Health, 2017). Seventy percent of this cost is 
attributed to injuries caused by spouse/domestic partner or a family member.  Furthermore, a 
study of hospital admissions following IPV in women in Western Australia found an overall 
increase in the number of IPV related admissions between 1990 and 2009 (Orr et al., 2019). 
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Outside of pregnancy there is research to confirm an increased vulnerability to IPV in 
women with severe mental illness (Trevillion et al., 2012). A systematic literature review of 24 
studies published between 1990 and 2017 focused on the extent that IPV adversely affects 
maternal mental health in pregnant women living in low and lower-middle income countries 
(Halim et al., 2018). This review concluded that there is a strong association between IPV and 
antenatal and postnatal depression. A systematic review and meta-analysis specifically 
examining IPV and perinatal mental health found depression, anxiety and Post-traumatic Stress 
Disorder (PTSD) were all associated with IPV (Howard et al., 2013). This systematic review 
identified no studies that examined in the perinatal period either psychotic disorders or bipolar 
disorder and domestic violence (Howard et al., 2013).  
Pregnancy and the first year postpartum are important as a foundation for offspring lifelong 
health and wellbeing and evidence for the potential detrimental impact of perinatal mental 
health is clear (Stein et al., 2014; Michel, 2001; Lewis et al., 2014; Galbally and Lewis, 2017). 
Further research has also confirmed the impact of poorer longer-term child outcomes where 
there is exposure to IPV in pregnancy (Murray et al., 2018).   
A possible mechanism for the impact of both IPV and also perinatal mental disorders on 
children’s socio-emotional and developmental outcomes is through the quality of maternal 
interaction, behaviour and the emerging parent-child relationship. It has been postulated that 
the association between maternal depression and poorer mental health outcomes for children is 
via this impact on interaction and relationship (Hayes et al., 2013; O'Donnell et al., 2014; 
Galbally and Lewis, 2017). 
While there has been much focus on the role of substances in the perpetration of IPV 
(Gilchrist et al., 2019) there has been less focus on whether victims of IPV are more vulnerable 
to substance misuse and whether that continues during pregnancy. Given the potential 
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implications for fetal and child development from exposure to substances such as alcohol this 
is an important association to understand (Polanska et al., 2015; Nygaard et al., 2017).  
On review of the current literature, there is only a single study published that has examined 
IPV and Severe Mental Illness (SMI) in pregnancy (Taylor et al., 2015). This study recruited 
456 pregnant women diagnosed with Bipolar Affective Disorder (BPAD) or psychotic 
disorders over a 4-year period (Taylor et al., 2015). The authors found that both women with 
psychotic disorders and those with bipolar disorders had high levels of domestic abuse in 
pregnancy (18.9%). However women with schizophrenia were less likely to have a partner and 
more likely to smoke and use substances during pregnancy and to have spent significantly more 
time in inpatient units in the two years before pregnancy compared to women with BPAD.  
Given the paucity of research on IPV, SMI and pregnancy, the aims of this current study 
are to firstly describe the rate of IPV that is experienced by pregnant women with SMI and 
compare this to the general population of pregnant women. Secondly, to examine IPV rates 
between pregnant women with Schizophrenia and related psychotic disorders and compare this 
to the rate of IPV against pregnant women with Bipolar Affective Disorder to determine if there 
is a difference between these two diagnostic groups. Thirdly, to examine the rate of comorbid 
alcohol, substance use and smoking in pregnant women with a SMI diagnosis and to examine 
whether there is a difference in alcohol, substance use and smoking amongst pregnant women 
with both SMI and IPV compared to pregnant women with SMI and no IPV.  
 
Methods 
The Childbirth and Mental Illness Clinic (CAMI) based at King Edward Memorial 
Hospital, Perth, Western Australia, Australia, offered a unique opportunity to collect data.. It 
comprises a multidisciplinary team including consultant psychiatrists, psychiatry trainees, GP 
obstetricians, social workers and midwives, and is overseen by a consultant obstetrician. Within 
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this clinic mental health diagnosis, is made by a consultant psychiatrist using ICD-10-AM 
criteria.20 
The sample comprised a retrospective analysis of the medical records of 304 pregnant 
women diagnosed with either Schizophrenia and related psychotic disorders or Bipolar 
Disorder who all attended the CAMI clinic at KEMH between 2006 to 2017. All files were 
reviewed using a pro-forma developed prior to data extraction. Data was extracted, de-
identified and entered on an Excel spreadsheet and stored securely in a health drive with 
password-protected access.  
Ethics 
The study was approved by the King Edward Memorial Hospital, Quality Improvement 
Committee within KEMH Human Research Ethics Committee (Approval Number 23560).  
Data Acquired 
Sociodemographic data collected included the women’s ages when admitted to CAMI and 
identification as Culturally and Linguistically Diverse (CaLD) or Aboriginal and Torres Strait 
Islander Australians. Previous psychiatric admissions including the number of previous 
admissions within a two-year period, together with data for past and current (current pregnancy) 
Child Protection and Family Support (CPFS) involvement, and past Statutory CPFS 
involvement were extracted. Binary data on the women’s current use of alcohol, smoking and 
illicit drugs were also extracted. A history of childhood trauma, including experienced, 
witnessed and childhood loss, were also extracted from the women’s files. IPV was identified 
through a routine screening form mandatory at KEMH for use for all antenatal women attending 
for care and through examination of the medical notes made by clinical team assessing the 
woman, including psychiatrist, social work, midwife and obstetric team.  
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SMI was determined using the primary mental health diagnosis recorded on the patient’s 
file. The CAMI has perinatal psychiatrists who assign diagnoses following a comprehensive 
assessment during intake. In this study, we grouped schizophrenia and other psychotic disorders 
in one group and bipolar disorders in a second. IPV data included binary incidence (No/Yes) 
of past or current IPV. We also used these data to create another composite binary variable to 
indicate any incidence IPV (past and current).  
Statistical Analysis 
Data were managed and descriptive statistics generated using SPSS 24 (IBM Corp., 2016). 
Risk ratios and associated significance tests were conducted using MedCalc for Windows, 
version 18.11. To analyse the results presented in this paper, we present frequency and 
percentage data representing rates within the CAMI sample. Risk Ratios were calculated to test 
inferentially the differences in the rates between groups. Risk ratios, 95% confidence intervals 
and exact p-values are reported. For the purposes of this study, statistical significance was 
defined as a p-value of less than .05. Where possible, comparisons were made between our 
study data and Australian population data reported by the Australian Bureau of Statistics, and 
the Australian Institute of Health and Welfare (Hilder et al., 2014; Cox, 2015; ABO, 2013). 
 
Results 
Sociodemographic Characteristics 
The average age of the 304 women attending CAMI at KEMH between 2006 and 2017 
was 29.86 (SD = 5.61), ranging between 17 and 44 years of age. The average age for women 
diagnosed with schizophrenia and related psychotic disorders (M = 30.58, SD = 5.87, min-max: 
19-44 years of age) did not differ significantly compared to women diagnosed with BPAD (M 
= 29.36, SD = 5.38, min-max: 17-42 years of age), F(1, 302) = 3.50, p = .062. Table 1 presents 
sociocultural and other characteristics of the total sample, and by SMI diagnosis. Of the total 
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sample, 41.1% were diagnosed with schizophrenia and related psychotic disorders, and 58.9% 
were diagnosed with BPAD. There were significantly more women with a schizophrenia or 
related psychotic diagnosis who identified as Aboriginal and Torres Strait Islander Australians, 
and CALD compared to women with a BPAD diagnosis. In the two years prior to the current 
presentation, half of women diagnosed with Schizophrenia and related psychotic disorders, and 
one third of women with BPAD, were admitted to a psychiatric hospital for treatment. Almost 
half of all women with Schizophrenia and related psychotic disorders, and one-fifth of women 
with BPAD, had current involvement with state CPFS service. Rates of previous psychiatric 
admission, past and current CPFS involvement, and past statutory CPFS involvement, were 
each significantly higher in women with a schizophrenia or related psychotic disorder diagnosis 
compared to women with a BPAD diagnosis. There were no significant differences between 
the diagnostic groupings for the rates of both experienced and witnessed childhood trauma, and 
childhood loss.   
INSERT TABLE 1 
IPV and SMI 
Table 2 shows the rates of IPV for women by SMI diagnosis. Almost half of all women 
with SMI (n=304) at CAMI had experienced IPV (n = 133, 43.8%), with nearly one-quarter 
experiencing IPV at the time of their current pregnancy (n = 62, 23.0%). Nearly half of all 
women with SMI at CAMI had experienced IPV prior to the current pregnancy (n = 118, 
45.9%). According to the Australian Bureau of Statistics, the rate of IPV in Australian women 
was 17%. When compared to the general population of Australian women, pregnant women 
with SMI admitted to CAMI were at more than triple the risk of experiencing or having 
experienced IPV (RR = 3.29 [95% CI: 2.91, 3.37], p <.001). 
INSERT TABLE 2 
During the current pregnancy, the rates of any IPV (past or current) in women with a 
diagnosis of schizophrenia was 46.4% and separately in women with a diagnosis of BPAD was 
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48.8% and did not differ significantly between these two groups of women. Almost half of 
pregnant women diagnosed with either schizophrenia or diagnosed with BPAD experienced 
past IPV, which did not differ significantly between these groups of women. Finally, almost 
one-quarter of all women diagnosed with either Schizophrenia or BPAD experienced IPV at 
the time of their current pregnancy and attended for antenatal care at CAMI clinic, which also 
did not differ significantly. 
Co-morbid Alcohol, Substance Use and Smoking in pregnant women with SMI in CAMI   
Table 2 also reports the rate of alcohol, smoking and illicit substance use in pregnant 
women with SMI. One-fifth of women diagnosed with SMI and attending CAMI reported 
alcohol (n = 57, 19.5%) and illicit substances (n = 64, 21.8%) use during pregnancy, and more 
than one-third of these women reported smoking during pregnancy (n = 100, 35.1%). When 
comparing women by SMI diagnosis, the rates of alcohol and illicit substance use did not differ 
significantly in women diagnosed with schizophrenia compared to women diagnosed with 
BPAD. However, the rate of smoking during pregnancy in women diagnosed with 
schizophrenia was significantly higher compared to the rate of women diagnosed with BPAD 
who smoked during pregnancy.  
Co-morbid Alcohol, Substance Use and Smoking in pregnant women with IPV in CAMI 
Table 3 presents the rates of alcohol, smoking and illicit substance by IPV group. Almost 
half of all pregnant women attending CAMI and having experienced any IPV (past or current) 
reported smoking, while almost one-third used illicit substances and one-quarter used alcohol. 
When compared to women with no experience of IPV within the CAMI sample, the rate of 
alcohol use during pregnancy was similar for women who had experienced IPV. However, the 
rates of illicit substance abuse and smoking were both significantly higher in women who had 
experienced IPV compared to women who had not experienced IPV in the CAMI sample.  
INSERT TABLE 3 
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Compared with data reported by the Australian Institute of Health and Welfare43, our 
results showed that pregnant women with any SMI diagnosis and IPV were significantly more 
likely to smoke (44.5% versus 11.3%, RR = 3.97 [2.98, 5.28], p < .001) and use illicit substances 
(29.9% versus 2.2%, RR = 13.65 [7.85, 23.73], p < .001) when compared to the Australian 
pregnant population. However, the rates of alcohol use in women in the CAMI sample who had 
experienced IPV were significantly lower compared to the general population of Australian 
pregnant women (23% versus 34.7%, RR = .66 [.48, .93], p < .017). 
 
Discussion 
This study found that pregnant women with SMI were 3 times higher risk of 
experiencing IPV compared to the rate for women subject to IPV in Australia. There was no 
significant difference in the rate of IPV between women diagnosed with Schizophrenia and 
those with BPAD. Furthermore, pregnant women with SMI who had a past or current history 
of IPV were more likely to smoke and use illicit substances during pregnancy.  
These findings add the increasing body of research that highlight a range of increased 
risks and poorer pregnancy outcomes for women with SMI (Galbally et al., 2019a; Galbally et 
al., 2019b; Judd et al., 2014; Nguyen et al., 2013). Indeed, women with SMI have higher risk 
pregnancies across a number of domains including obstetric and neonatal as well as the 
psychosocial risks for both IPV and smoking and substance use highlighted in this study. 
Together this supports the development of specific models of antenatal care to ensure the 
appropriate obstetric, psychiatric and neonatal care can be co-ordinated to optimise outcomes 
for women and children (Galbally et al., 2010; Nguyen et al., 2013; Van Deinse et al., 2019).  
Overall, this study found pregnant women diagnosed with schizophrenia were more 
likely to smoke, use alcohol and illicit substances compared to pregnant women diagnosed with 
BPAD. It was notable and unexpected in our cohort, that pregnant women with SMI and IPV 
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were not more likely to consume alcohol during pregnancy. One possible explanation could be 
the attention that is currently given by media and labelling of alcohol that highlights the 
detrimental use of alcohol in pregnancy. In addition, local health services have focused on 
education and reduction in alcohol use in pregnant women in response to high identified rates 
of fetal alcohol spectrum disorder in Western Australia.  
Our findings confirm data from the only other study reporting data on SMI and IPV in 
pregnancy. This U.K study also reported an elevated risk for IPV in pregnant women with SMI. 
It found that 34.9% of women with SMI reported past IPV and 18.9% reported IPV during 
current pregnancy (Taylor et al., 2015). Our study provides data specifically on Australian 
women and when comparing our data to the UK findings, our cohort were more likely to 
experience IPV than pregnant women within this study of women with SMI in the UK. Our 
cohort also had higher rates of smoking (35.1% cf. 17.3%), alcohol (19.5% cf. 16.9%) and 
illicit substance use (21.8% cf. 13.4%) than the rates reported in UK study. 
A review of the literature indicated the paucity of reported research on IPV in pregnant 
women diagnosed with SMI, with no reported studies on Australian women diagnosed with 
SMI. Therefore, the contributions of this retrospective cross-sectional chart review are two-
fold. It adds to the currently limited data available identifying the prevalence of IPV in pregnant 
women with SMI and also shows the impact on specific co-morbidity with substance use, 
finding a significant increase of smoking and illicit substance use in pregnant women with SMI 
and IPV. This study shows that in a sample of Australian pregnant women with SMI, IPV 
experiences are common, and this group of women should be regarded as high risk for IPV.  
While the relationship between experiencing IPV and substance use in pregnancy has been 
previously examined, as far as we are aware this is the first study that examines this relationship 
between pregnancy, SMI, IPV and substance use. This is important in understanding additional 
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risks and the potential impact of smoking, substance and alcohol use in pregnant women 
experiencing IPV and who have a SMI diagnosis.  
The rate of screening for IPV within antenatal and mental health care is often reported 
as low despite an increasing focus on policy that would support this practice. Indeed a survey 
of mental health professionals’ knowledge and skills in IPV in the Netherlands found low levels 
of both knowledge and confidence supporting the need for more education and focus on IPV 
within mental health (Ruijne et al., 2019) with similar findings are in other jurisdictions 
(Trevillion et al., 2016). Furthermore, a survey of mental health clinicians training found few 
had adequate training in assessment and identification of IPV (Forsdike et al., 2019). This was 
confirmed in a study of professionals specifically in relation to SMI, FDV and pregnancy (Van 
Deinse et al., 2019). This study found women with SMI in pregnancy were likely to face greater 
hurdles in accessing support from relevant service providers.  
Australian research on screening for IPV confirms the importance of screening within 
the health systems if there is to be the identification, response and then ultimately a reduction 
in harm to women and children from IPV (Spangaro, 2018; Spangaro et al., 2016). In Australian 
jurisdictions where routine antenatal screening occurs there is a reported screening rate of 62-
75%, indicating that it is possible to integrate routine screening into perinatal and maternity 
health settings (Spangaro et al., 2011a). Together these findings are relevant to service 
implementation and practice for both mental health care and antenatal care, emphasising the 
importance of assessing for IPV in women with SMI and the importance of identifying specific 
comorbidities including smoking, alcohol and substance use which are risk factors in pregnancy 
(Spangaro et al., 2011b). However, there are no doubt challenges, particularly for IPV screening 
in Aboriginal and Torre Strait Islander and Culturally and Linguistically Diverse women, where 
the stigma in reporting IPV in the antenatal setting may be much higher and adaptations to 
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screening protocols and approaches may need to be considered to ensure there is cultural safety 
and acceptability.  
 
This study has several limitations. The retrospective nature of the data collection means 
that the accuracy of the study findings is dependent upon the thoroughness of the recording of 
clinical information in the patient record. Disclosure of partner abuse is a sensitive issue and it 
is possible that pregnant women with SMI minimised or failed to disclose their IPV 
experiences.  
 
Conclusions 
Psychiatrists and mental health services who manage pregnant women require a clear 
understanding of psychosocial risks including IPV which is core to providing holistic care. For 
many women with SMI contact with primary care may be limited and paired with irregular 
attendance at antenatal care, hence the importance of mental health clinicians in assessing for 
associated risks such as IPV.  
This retrospective study has also revealed several areas for future research such as the need 
for studies evaluating the risk of harm to pregnant women with SMI and their infants when 
women are also experiencing intimate partner violence.  In addition, the examination of barriers 
associated with assessing and screening for IPV in pregnant women with SMI and evaluation 
of screening specifically in this group of pregnant women.  Given the high rate of IPV in 
pregnant women with SMI and expanding this focus to non-pregnant women with SMI to 
examine IPV rates might also be beneficial.  
Our findings suggest the importance of incorporating IPV screening as part of antenatal 
and mental health care and adopting processes to support the early identification, early 
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intervention and appropriate management of women and their babies at increased risk of harm. 
While there may be barriers including under-reporting and stigma associated with IPV 
screening, it is clear the high risks of health systems ignoring IPV for women and their unborn 
children.  
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Table 1. Characteristics of the Total CAMI Sample, and by SMI Diagnosis. 
 
Diagnosed with 
Schizophrenia 
Diagnosed 
with BPAD   
Total 
Sample 
  (n = 125) (n = 179)  (N = 304) 
  n % n %   n % 
Aboriginal and Torres Strait 
Islander Australians 
27 22.0a 10 5.7a   37 12.4 
CALD 29 33.4a 18 10.2a  47 15.7 
Nulliparous 50 40.0 88 49.2  138 45.4 
Previous Psychiatric Admission 63 52.9a 50 31.1a  113 40.4 
Current CPFS Involvement 54 44.3a 35 20.1a  89 30.1 
Past CPFS Involvement 33 26.8a 23 13.5a  56 19.0 
Past Statutory CPFS Involvement 28 22.6a 13 7.5a  41 13.8 
Childhood Trauma - Experienced 39 40.2 64 44.8  103 42.9 
Childhood Trauma - Witnessed 31 32.6 38 26.4  69 28.9 
Childhood Loss 21 21.2 29 19.3   50 20.1 
a Denotes proportions that differ significantly at p < .05 between SMI Diagnoses, 
Schizophrenia and BPAD, using a Chi-square Test of Independence. 
Abbreviations: SMI, Severe Mental Illness, CAMI, Childbirth and Mental Illness Clinic, 
CALD, Culturally and Linguistically Diverse; CPFS, Child Protection and Family Support. 
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Table 2. Intimate Partner Violence (IPV), and Substance Use and Abuse Rates for 
Pregnant Women with SMI diagnosis at CAMI Clinic (N = 304). 
 
Diagnosed with 
Schizophrenia  
(n = 125) 
Diagnosed with 
BPAD  
(n = 179) 
RR [95% CI's] p-value  n % n % 
IPV Any 52 46.4 81 48.8 .95 [.74, 1.23] .700 
IPV Current 24 22.4 38 23.3 .96 [.61, 1.51] .866 
IPV Past 47 46.1 71 45.8 1.01 [.77, 1.32] .966 
Alcohol Use 26 20.8 31 17.3 1.21 [.76, 1.93] .425 
Illicit Substance Use 34 28.1 30 17.3 1.54 [1.00, 2.36] .051 
Smoking 54 45.0 46 27.9 1.61 [1.18, 2.21] .003 
Abbreviations: SMI, Severe Mental Illness, CAMI, Childbirth and Mental Illness Clinic 
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Table 3. Rates of Substance Use and Abuse for Pregnant Women Diagnosed with 
SMI at CAMI Clinic by any IPV Experience (N = 304). 
 
IPV (n = 133) 
No IPV  
(n = 145)  RR [95% CI's] p-value 
  n % n %   
Alcohol Use 29 23.0 25 17.2 1.33 [.82, 2.15] .237 
Illicit Substance Use 38 29.9 19 13.1 2.28 [1.39, 3.75] .001 
Smoking 59 44.5 39 37.1 1.64 [1.18, 2.30] .004 
Abbreviations: SMI, Severe Mental Illness, CAMI, Childbirth and Mental Illness Clinic 
 
